- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.12.25 | EPIMINDER LIMITED: Finalisation of historical R&D tax claims | 6 | ASX | ||
| 15.12.25 | EPIMINDER LIMITED: Company Secretary Appointment/Resignation | 2 | ASX | ||
| EPIMINDER Aktie jetzt für 0€ handeln | |||||
| 15.12.25 | EPIMINDER LIMITED: Change of Director's Interest Notice | 4 | ASX | ||
| 14.12.25 | EPIMINDER LIMITED: Change of Director's Interest Notice DO | 3 | ASX | ||
| 11.12.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 11.12.2025 | 438 | Xetra Newsboard | The following instruments on XETRA do have their first trading 11.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 11.12.2025
Aktien
1 AU0000410128 Ariana Resources PLC
2... ► Artikel lesen | |
| 08.12.25 | EPIMINDER LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 07.12.25 | EPIMINDER LIMITED: Change of Director's Interest Notice RK | - | ASX | ||
| 05.12.25 | Scott Power: ASX healthcare stocks fall as Epiminder slumps on IPO | 1 | Stockhead | ||
| 05.12.25 | EPIMINDER LIMITED: Change of Director's Interest Notice R Klupacs | - | ASX | ||
| 02.12.25 | EPIMINDER LIMITED: Initial Director's Interest Notice | 1 | ASX | ||
| 02.12.25 | EPIMINDER LIMITED: Becoming a substantial holder | 1 | ASX | ||
| 02.12.25 | EPIMINDER LIMITED: Becoming a substantial holder | 1 | ASX | ||
| 02.12.25 | EPIMINDER LIMITED: Initial Director's Interest Notice | 1 | ASX | ||
| 02.12.25 | EPIMINDER LIMITED: Initial Director's Interest Notice | 1 | ASX | ||
| 02.12.25 | EPIMINDER LIMITED: Initial Director's Interest Notice | 2 | ASX | ||
| 02.12.25 | EPIMINDER LIMITED: Initial Director's Interest Notice | 1 | ASX | ||
| 02.12.25 | EPIMINDER LIMITED: Becoming a substantial holder | 1 | ASX | ||
| 02.12.25 | EPIMINDER LIMITED: Epiminder Listing and Business Update | 1 | ASX | ||
| 27.11.25 | EPIMINDER LIMITED: Pre-Quotation Disclosure | - | ASX | ||
| 27.11.25 | EPIMINDER LIMITED: Top 20 Holders | - | ASX |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GENEDX | 109,28 | 0,00 % | Sema4.ai: Interview With Co-Founder & CEO Rob Bearden About The Enterprise AI Agent Platform | ||
| ALIGNMENT HEALTHCARE | 22,500 | 0,00 % | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 | Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year... ► Artikel lesen | |
| HEARTFLOW | 36,120 | +3,26 % | Heartflow, Inc. - 8-K, Current Report | ||
| BETA BIONICS | 17,790 | +4,71 % | Faruqi & Faruqi LLP: SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics | Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses in Beta Bionics to Contact Him Directly to Discuss Their OptionsIf you... ► Artikel lesen | |
| PROGYNY | 24,310 | -6,91 % | Progyny, Inc. - 8-K, Current Report | ||
| BRIGHTSPRING HEALTH SERVICES | 39,610 | +3,02 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| FRESENIUS | 50,66 | +2,03 % | dpa-AFX-Überblick: UNTERNEHMEN vom 09.01.2026 - 15.15 Uhr | ROUNDUP: Teamviewer erreicht Umsatzziel für 2025 - Aktie mit Erholungsversuch GÖPPINGEN - Der Softwareanbieter Teamviewer hat 2025 sein im Herbst gesenktes Umsatzziel knapp erreicht. Basierend auf... ► Artikel lesen | |
| ADAPTHEALTH | 10,640 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| FRESENIUS MEDICAL CARE | 37,270 | +1,33 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,720 | -0,17 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers auf "Outperform" mit einem Kursziel von 52,90 Euro belassen. 2025 sei ein schlechtes Jahr... ► Artikel lesen | |
| BILLIONTOONE | 94,72 | +0,37 % | BillionToOne, Inc.: BillionToOne Provides Guidance for 2026 | MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 30,520 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,440 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 7,680 | +2,40 % | H.C. Wainwright bestätigt Kaufempfehlung für Alpha Tau Medical nach positiven Studiendaten | ||
| AVEANNA HEALTHCARE | 9,770 | +4,60 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen |
Das Unternehmen EPIMINDER LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,502 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPIMINDER LIMITED finden Sie auf Wallstreet Online.